Erratum to “Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid” [Biochem. Biophys. Res. Commun. 320 (2004) 1199–1203]

Documenti analoghi

• Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid
  di: He, Runtao, et al.
  Pubblicazione: (2004)
• Aurintricarboxylic Acid Inhibits the Early Stage of Vaccinia Virus Replication by Targeting both Cellular and Viral Factors
  di: Myskiw, Chad, et al.
  Pubblicazione: (2007)
• Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
  di: Hashem, Anwar M., et al.
  Pubblicazione: (2009)
• Correction: Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
  di: Hashem, Anwar M., et al.
  Pubblicazione: (2013)
• Erratum to “Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS” [Biochem. Biophys. Res. Commun. 308 (2003) 148–151]
  di: Chou, Kuo-Chen, et al.
  Pubblicazione: (2003)